Stock Analysis on Net
Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

Debt to Equity
since 2005

Microsoft Excel

Calculation

Allergan PLC, debt to equity, long-term trends, calculation

Microsoft Excel
Debt to equity = Total debt and capital leases1 ÷ Shareholders’ equity1
Dec 31, 2019 0.39 = 22,649,000 ÷ 58,173,600
Dec 31, 2018 0.37 = 23,797,700 ÷ 65,114,100
Dec 31, 2017 0.41 = 30,075,300 ÷ 73,821,100
Dec 31, 2016 0.43 = 32,768,700 ÷ 76,192,700
Dec 31, 2015 0.56 = 42,726,200 ÷ 76,591,400
Dec 31, 2014 0.55 = 15,543,700 ÷ 28,331,100
Dec 31, 2013 0.95 = 9,052,000 ÷ 9,532,100
Dec 31, 2012 1.68 = 6,433,300 ÷ 3,833,800
Dec 31, 2011 0.29 = 1,033,000 ÷ 3,563,600
Dec 31, 2010 0.31 = 1,016,100 ÷ 3,281,700
Dec 31, 2009 0.48 = 1,457,800 ÷ 3,023,100
Dec 31, 2008 0.42 = 877,893 ÷ 2,108,585
Dec 31, 2007 0.49 = 905,649 ÷ 1,849,465
Dec 31, 2006 0.73 = 1,231,204 ÷ 1,680,388
Dec 31, 2005 0.28 = 587,935 ÷ 2,104,241

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands

Comparison to Competitors

Allergan PLC, debt to equity, long-term trends, comparison to competitors

Microsoft Excel
Allergan PLC AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Moderna Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
Dec 31, 2019 0.39 — 3.09 0.91 0.72 5.88 1.09 0.47 1.02 0.03 0.83 0.06 0.60
Dec 31, 2018 0.37 — 2.71 0.52 0.35 1.30 1.28 0.51 0.94 0.03 0.66 0.08 0.69
Dec 31, 2017 0.41 7.33 1.40 0.68 0.40 1.18 1.64 0.57 0.71 — 0.60 0.11 0.83
Dec 31, 2016 0.43 7.95 1.16 0.41 0.53 0.74 1.39 0.39 0.62 — 0.71 0.11 0.77
Dec 31, 2015 0.56 8.03 1.12 0.47 0.54 0.55 1.20 0.28 0.59 — 0.60 0.10 0.59
Dec 31, 2014 0.55 8.62 1.19 0.53 0.15 0.52 0.80 0.27 0.44 — 0.51 0.18 0.71
Dec 31, 2013 0.95 3.28 1.45 0.55 0.16 0.30 0.58 0.25 0.50 — 0.48 0.26 0.62
Dec 31, 2012 1.68 4.66 1.39 0.54 0.28 0.37 0.88 0.25 0.39 — 0.46 0.37 0.46
Dec 31, 2011 0.29 — 1.13 0.34 0.31 0.52 1.13 0.34 0.32 — 0.47 0.90 0.47
Dec 31, 2010 0.31 — 0.56 0.35 0.21 0.56 0.59 0.30 0.33 — 0.50 0.31 0.14
Dec 31, 2009 0.48 — 0.47 0.43 0.25 0.70 0.18 0.29 0.30 — 0.54 0.27 0.14
Dec 31, 2008 0.42 — 0.50 0.55 0.27 1.55 0.31 0.28 0.33 — 0.30 0.00 0.14
Dec 31, 2007 0.49 — 0.63 0.59 0.41 0.37 0.38 0.22 0.32 — 0.20 0.43 0.15
Dec 31, 2006 0.73 — 0.48 0.74 0.37 0.34 0.77 0.17 0.39 — 0.11 0.92 0.19
Dec 31, 2005 0.28 — 0.19 0.77 0.21 0.60 0.10 0.07 0.45 — 0.27 1.75 0.21

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Allergan PLC, debt to equity, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Allergan PLC Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2019 0.39 1.10
Dec 31, 2018 0.37 0.94
Dec 31, 2017 0.41 0.88
Dec 31, 2016 0.43 0.79
Dec 31, 2015 0.56 0.68
Dec 31, 2014 0.55 0.55
Dec 31, 2013 0.95 0.52
Dec 31, 2012 1.68 0.51
Dec 31, 2011 0.29 0.46
Dec 31, 2010 0.31 0.39
Dec 31, 2009 0.48 0.39
Dec 31, 2008 0.42 0.37
Dec 31, 2007 0.49 0.30
Dec 31, 2006 0.73 0.25
Dec 31, 2005 0.28 0.29

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Allergan PLC, debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel
Allergan PLC Health Care
Dec 31, 2019 0.39 0.91
Dec 31, 2018 0.37 0.87
Dec 31, 2017 0.41 0.79
Dec 31, 2016 0.43 0.75
Dec 31, 2015 0.56 0.68
Dec 31, 2014 0.55 0.52
Dec 31, 2013 0.95 0.49
Dec 31, 2012 1.68 0.51
Dec 31, 2011 0.29 0.45
Dec 31, 2010 0.31 0.41
Dec 31, 2009 0.48 0.41
Dec 31, 2008 0.42 0.41
Dec 31, 2007 0.49 0.36
Dec 31, 2006 0.73 0.33
Dec 31, 2005 0.28 0.30

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).